1 unchanged sentence
Rule 10b5-1 Trading Arrangements
−Removed: On March 11, 2025 , Kevin Norrett , our Chief Operating Officer , adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
−Removed: The plan provides for the sale of up to 66,602 shares of the Company’s common stock and will terminate on January 30, 2026 , subject to early termination for certain specified events set forth in the plan.
−Removed: During the three months ended March 31, 2025, except as set forth above, none of the directors or executive officers of the Company adopted or terminated any contracts, instructions, or written plans for the purchase or sale of our securities that were intended to meet the affirmative defense conditions of Rule 10b5-1(c) or any other non-Rule 10b5-1 trading arrangement.
+Added: During the three months ended June 30, 2025, none of the directors or executive officers of the Company adopted or terminated any contracts, instructions, or written plans for the purchase or sale of our securities that were intended to meet the affirmative defense conditions of Rule 10b5-1(c) or any other non-Rule 10b5-1 trading arrangement.
3.1 Amended and Restated Certificate of Incorporation of Codexis, Inc.
6 unchanged sentences
4.2 Form of the Company’s Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, filed on August 9, 2012).
−Removed: 4.3 Form of Warrant to Purchase Common Stock for Codexis, Inc., issued pursuant to the Loan and Security Agreement by and between the Company and Innovatus Life Sciences Fund I, LP.
−Removed: (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on February 13, 2024).
4.3 Description of Codexis' Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.
( incorporated by reference to Exhibit 4.4 to the Company’s Annual Report on Form 10-K, filed on February 28, 2024).
−Removed: 10.1 A mendment No 1 .
−Removed: to the Acquisition Agreement by and among the Company, Societé des Produits Nestlé S.A., formerly known as Nestec Ltd.
−Removed: ("Nestlé Health Science"), effective as of February 28 , 2025.
+Added: 10.1 + Second Amendment to the Codexis, Inc.
+Added: 2019 Incentive Award Plan, as amended.
31.1 Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.
1 unchanged sentence
32.1 Certification of Principal Executive Officer and Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C.
−Removed: 101 The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline Extensible Business Reporting Language (iXBRL) includes:
−Removed: (i) Unaudited Condensed Consolidated Balance Sheets at March 31, 2025 and December 31, 2024 (ii) Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024, (iii) Unaudited Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2025 and 2024, (iv) Unaudited Condensed Consolidated Statements of Stockholders' Equity for the three months ended March 31, 2025 and 2024, (v) Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024 and (v) Notes to Unaudited Condensed Consolidated Financial Statements.
+Added: 101 The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline Extensible Business Reporting Language (“iXBRL”) includes:
+Added: (i) Unaudited Condensed Consolidated Balance Sheets at June 30, 2025 and December 31, 2024 (ii) Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2025 and 2024, (iii) Unaudited Condensed Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended June 30, 2025 and 2024, (iv) Unaudited Condensed Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended June 30, 2025 and 2024, (v) Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024 and (v) Notes to Unaudited Condensed Consolidated Financial Statements.
101.SCH Inline XBRL Taxonomy Extension Schema Document
3 unchanged sentences
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: 104 The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL and contained in Exhibit 101.
+Added: 104 The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline XBRL and contained in Exhibit 101.
+Added: + Indicates a management contract or compensatory plan or arrangement.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Codexis, Inc.
−Removed: May 14, 2025 By:
+Added: August 13, 2025 By:
/s/ Stephen Dilly
2 unchanged sentences
(principal executive officer)
−Removed: May 14, 2025 By:
+Added: August 13, 2025 By:
/s/ Georgia Erbez
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.